Quantum Biopharma (QNTM) Interest Expenses (2019 - 2026)
Quantum Biopharma (QNTM) reported Interest Expenses of $22854.0 for Q1 2026, down 9.93% on a YoY basis from $25374.0 in Q1 2025, and up 131.46% sequentially from -$72637.0 in Q4 2025.
Quantum Biopharma (QNTM) Interest Expenses (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Interest Expenses data on file, last reported at $22854.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses fell 9.93% year-over-year to $22854.0; the trailing twelve-month figure through Mar 2026 stood at $158749.0 (up 245.28% YoY), and the FY2025 full-year result was $158063.0, up 378.73% from the prior year.
- Interest Expenses improved to $22854.0 in Q1 2026, from -$72637.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $116962.0 in Q2 2025 to a low of -$72637.0 in Q4 2025.
- A 5-year average of $16759.5 and a median of $11392.5 in 2024 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 1299.57% in 2025, while the deepest fall reached 3973.97% in 2025.
- Tracing QNTM's Interest Expenses over 5 years: stood at $5208.0 in 2022, then plunged by 501.34% to -$20902.0 in 2023, then soared by 108.97% to $1875.0 in 2024, then plunged by 3973.97% to -$72637.0 in 2025, then soared by 131.46% to $22854.0 in 2026.
- Business Quant data shows QNTM's Interest Expenses at $22854.0 in Q1 2026, -$72637.0 in Q4 2025, and $91570.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | 22,854.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,854.00 |
| Mar 31, 2026 | 22,854.00 |
| Dec 31, 2025 | -72,637.00 |
| Dec 31, 2025 | -72,637.00 |
| Sep 30, 2025 | 91,570.00 |
| Sep 30, 2025 | 91,570.00 |
| Jun 30, 2025 | 116,962.00 |
| Jun 30, 2025 | 116,962.00 |
| Mar 31, 2025 | 25,374.00 |
| Mar 31, 2025 | 25,374.00 |
| Dec 31, 2024 | 1,875.00 |
| Dec 31, 2024 | 1,875.00 |
| Sep 30, 2024 | 10,371.00 |
| Sep 30, 2024 | 10,371.00 |
| Jun 30, 2024 | 8,357.00 |
| Jun 30, 2024 | 8,357.00 |
| Mar 31, 2024 | 12,414.00 |
| Mar 31, 2024 | 12,414.00 |
| Dec 31, 2023 | -20,902.00 |
| Dec 31, 2023 | -20,902.00 |